Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ITGAV/ITGB6 anticorps

ITGAV/ITGB6 Reactivité: Humain, Souris, Rat FACS, WB, IF (cc), IF (p), IHC (fro), ELISA, IHC (p) Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN714806
  • Antigène Tous les produits ITGAV/ITGB6
    ITGAV/ITGB6 (Integrin AlphaV Beta6 (ITGAV/ITGB6))
    Reactivité
    • 19
    • 16
    • 16
    • 1
    Humain, Souris, Rat
    Hôte
    • 15
    • 3
    • 1
    Lapin
    Clonalité
    • 15
    • 4
    Polyclonal
    Conjugué
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp ITGAV/ITGB6 est non-conjugé
    Application
    • 17
    • 16
    • 12
    • 12
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
     Réactivité croisée
    Humain, Souris, Rat
    Purification
    Purified by Protein A.
    Immunogène
    KLH conjugated synthetic peptide derived from human Integrin Alpha V + Beta 6
    Isotype
    IgG
  • Indications d'application
    WB 1:300-5000
    ELISA 1:500-1000
    FCM 1:20-100
    IHC-P 1:200-400
    IHC-F 1:100-500
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 μg/μL
    Buffer
    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
    Date de péremption
    12 months
  • Cargnoni, Farigu, Cotti Piccinelli, Bonassi Signoroni, Romele, Vanosi, Toschi, Cesari, Barros SantAnna, Magatti, Silini, Parolini: "Effect of human amniotic epithelial cells on pro-fibrogenic resident hepatic cells in a rat model of liver fibrosis." dans: Journal of cellular and molecular medicine, Vol. 22, Issue 2, pp. 1202-1213, (2017) (PubMed).

    Gao, Gao, Zhang, Liu, Jia, Zhu, Wang, Liu: "A near-infrared phthalocyanine dye-labeled agent for integrin ?v?6-targeted theranostics of pancreatic cancer." dans: Biomaterials, Vol. 53, pp. 229-38, (2015) (PubMed).

    Li, Huang, Gao, Chen, Zhang, Zheng: "Scutellarin inhibits the growth and invasion of human tongue squamous carcinoma through the inhibition of matrix metalloproteinase-2 and -9 and αvβ6 integrin." dans: International journal of oncology, Vol. 42, Issue 5, pp. 1674-81, (2013) (PubMed).

  • Antigène
    ITGAV/ITGB6 (Integrin AlphaV Beta6 (ITGAV/ITGB6))
    Autre désignation
    Integrin Alpha V + Beta 6 (ITGAV/ITGB6 Produits)
    Sujet

    Synonyms: CD51, Integrin alpha-V light chain, integrin, alpha V vitronectin receptor, alpha polypeptide, antigen CD51, Integrin, alpha V, Integrin, beta 6, ITAV_HUMAN, ITGAV, ITGB6, Vitronectin receptor subunit alpha.

    Background: Integrins are heterodimeric cell surface receptors composed of alpha and beta subunits, which mediate cell-cell and cell-extracellular matrix attachments. Aberrant integrin expression has been found in many epithelial tumours. Changes in integrin expression have been shown to be important for the growth and early metastatic capacity of melanoma cells. Integrin alpha-v beta-6 is upregulated in cancers and during tissue remodelling but is absent from resting adult tissues. Integrin alpha-v beta-6 promotes invasion and correlates with poor survival and therefore makes a promising therapeutic target.

    ID gène
    36853694
Vous êtes ici:
Support technique